National Advisory Child Health and Human Development Council Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) Implementation Working Group Meeting, 10088 [2024-02904]

Download as PDF 10088 Federal Register / Vol. 89, No. 30 / Tuesday, February 13, 2024 / Notices 2023, and January 5, 2024, concerning updates to the Bright Futures Periodicity Schedule as part of the HRSA-supported preventive services guidelines for infants, children, and adolescents. These documents contained minor errors related to updates to two footnotes, including an error in the text of footnote 15 and an error in the description of footnote 21. These minor corrections align with information provided to the public on the Bright Futures web page and referenced by HRSA in the October 24, 2023, Federal Register notice that sought public comment on the proposed updates to the Bright Futures Periodicity Schedule. These corrections do not change the clinical recommendations in the Bright Futures Periodicity Schedule or the associated requirement for certain group health plans and health insurance issuers to provide coverage without cost-sharing under section 2713 of the Public Health Service Act. FOR FURTHER INFORMATION CONTACT: Savannah Kidd, M.S. MFT, Sr. Public Health Advisor, Division of Child, Adolescent and Family Health, Maternal and Child Health Bureau, HRSA, telephone: (301) 287–2601, email: SKidd@hrsa.gov. SUPPLEMENTARY INFORMATION: lotter on DSK11XQN23PROD with NOTICES1 Correction In the Federal Register of January 5, 2024, FR Doc. 2024–00024, on page 790, column 3, paragraph 2, correct the text of updated footnote 15 to read as follows: ‘‘A recommended tool to assess use of alcohol, tobacco and nicotine, and marijuana and other substances, including opioids, is available at https:// crafft.org.’’ The document incorrectly omitted the phrase, ‘‘and other substances, including opioids,’’ in this sentence. In the Federal Register of January 5, 2024, FR Doc. 2024–00024, on page 790, column 3, paragraph 3, correct the description of the update to footnote 21 to read as follows: ‘‘This updated reference aligns with the Bright Futures recommendation for universal bilirubin screening for all newborn infants between 24 and 48 hours after birth.’’ The document incorrectly included the phrase ‘‘between 24 and 28 hours after birth’’ in this sentence. In the Federal Register of October 24, 2023, FR Doc. 2023–23396, on page 73035, column 3, paragraph 3, correct the description of the proposed update to footnote 21 to read as follows: ‘‘This reference aligns with the Bright Futures recommendation for universal bilirubin screening for all newborn infants VerDate Sep<11>2014 16:57 Feb 12, 2024 Jkt 262001 between 24 and 48 hours after birth.’’ The document incorrectly included the phrase ‘‘between 24 and 28 hours after birth.’’ Maria G. Button, Director, Executive Secretariat. [FR Doc. 2024–02959 Filed 2–12–24; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Advisory Child Health and Human Development Council Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) Implementation Working Group Meeting AGENCY: National Institutes of Health, HHS. ACTION: Notice. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) PRGLAC Implementation Working Group of Council is charged with monitoring and reporting on implementation of the recommendations from the PRGLAC. This includes monitoring and reporting on implementation, updating regulations, and guidance, as applicable, regarding the inclusion of pregnant women and lactating women in clinical trials. DATES: The in-person meeting will be held on March 22, 2024, from 8:30 a.m. to 4:30 p.m. EST. ADDRESSES: The in-person meeting will be held on the NIH Campus, 1 Center Dr., Building 31/6C, Room A, Bethesda, MD 20892. FOR FURTHER INFORMATION CONTACT: For information concerning this meeting, Dr. Emma Carpenter, Health Science Policy Analyst, Legislation and Public Policy Branch, Office of Legislation, Public Policy, and Ethics, NICHD, NIH, 6710B Rockledge Drive, Bethesda, MD 20892–7510, emma.carpenter@nih.gov, 301–594–2572. SUPPLEMENTARY INFORMATION: This notice is pursuant to 42 U.S.C. 285g. The National Advisory Child Health and Human Development Council Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) Implementation Working Group meeting will be open to the public as a virtual meeting. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should SUMMARY: PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 notify the Contact Person listed in advance of the meeting. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nichd.nih.gov/about/advisory, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS). Alison N. Cernich, Deputy Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. [FR Doc. 2024–02904 Filed 2–12–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2023–0672] Collection of Information Under Review by Office of Management and Budget; OMB Control Number 1625– 0031 Coast Guard, DHS. Thirty-day notice requesting comments. AGENCY: ACTION: In compliance with the Paperwork Reduction Act of 1995 the U.S. Coast Guard is forwarding an Information Collection Request (ICR), abstracted below, to the Office of Management and Budget (OMB), Office of Information and Regulatory Affairs (OIRA), requesting an extension of its approval for the following collection of information: 1625–0031, Plan Approval and Records for Electrical Engineering Regulations—Title 46 CFR Subchapter J; without change. Our ICR describes the information we seek to collect from the public. Review and comments by OIRA ensure we only impose paperwork burdens commensurate with our performance of duties. DATES: You may submit comments to the Coast Guard and OIRA on or before March 14, 2024. SUMMARY: E:\FR\FM\13FEN1.SGM 13FEN1

Agencies

[Federal Register Volume 89, Number 30 (Tuesday, February 13, 2024)]
[Notices]
[Page 10088]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02904]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Advisory Child Health and Human Development Council Task 
Force on Research Specific to Pregnant Women and Lactating Women 
(PRGLAC) Implementation Working Group Meeting

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Eunice Kennedy Shriver National Institute of Child Health 
and Human Development (NICHD) PRGLAC Implementation Working Group of 
Council is charged with monitoring and reporting on implementation of 
the recommendations from the PRGLAC. This includes monitoring and 
reporting on implementation, updating regulations, and guidance, as 
applicable, regarding the inclusion of pregnant women and lactating 
women in clinical trials.

DATES: The in-person meeting will be held on March 22, 2024, from 8:30 
a.m. to 4:30 p.m. EST.

ADDRESSES: The in-person meeting will be held on the NIH Campus, 1 
Center Dr., Building 31/6C, Room A, Bethesda, MD 20892.

FOR FURTHER INFORMATION CONTACT: For information concerning this 
meeting, Dr. Emma Carpenter, Health Science Policy Analyst, Legislation 
and Public Policy Branch, Office of Legislation, Public Policy, and 
Ethics, NICHD, NIH, 6710B Rockledge Drive, Bethesda, MD 20892-7510, 
[email protected], 301-594-2572.

SUPPLEMENTARY INFORMATION: This notice is pursuant to 42 U.S.C. 285g. 
The National Advisory Child Health and Human Development Council Task 
Force on Research Specific to Pregnant Women and Lactating Women 
(PRGLAC) Implementation Working Group meeting will be open to the 
public as a virtual meeting. Individuals who need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed in advance of 
the meeting.
    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Information is also available on the 
Institute's/Center's home page: https://www.nichd.nih.gov/about/advisory, where an agenda and any additional information for the 
meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS).

Alison N. Cernich,
Deputy Director, Eunice Kennedy Shriver National Institute of Child 
Health and Human Development, National Institutes of Health.
[FR Doc. 2024-02904 Filed 2-12-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.